PUBLICATION
            Dominant-Negative ALK2 Allele Associates With Congenital Heart Defects
- Authors
- Smith, K.A., Joziasse, I.C., Chocron, S., van Dinther, M., Guryev, V., Verhoeven, M.C., Rehmann, H., van der Smagt, J.J., Doevendans, P.A., Cuppen, E., Mulder, B.J., Ten Dijke, P., and Bakkers, J.
- ID
- ZDB-PUB-090616-45
- Date
- 2009
- Source
- Circulation 119(24): 3062-3069 (Journal)
- Registered Authors
- Bakkers, Jeroen, Chocron, Sonja, Cuppen, Edwin, Guryev, Victor, Smith, Kelly
- Keywords
- ALK2 protein, human, genes, heart defects, congenital, screening, signal transduction
- MeSH Terms
- 
    
        
        
            
                - Genes, Dominant*
- Amino Acid Substitution
- Cattle
- Zebrafish/embryology
- Zebrafish/genetics
- Heart/embryology
- Heart/physiopathology
- Alleles*
- Heart Septal Defects/genetics
- Heart Septal Defects/metabolism*
- Heart Septal Defects/physiopathology
- Activin Receptors, Type I/genetics
- Activin Receptors, Type I/metabolism*
- Netherlands
- Chlorocebus aethiops
- Female
- Humans
- Animals
- Myocardium/metabolism
- Mutation, Missense
- Male
- Polymorphism, Single Nucleotide*
- COS Cells
 
- PubMed
- 19506109 Full text @ Circulation
            Citation
        
        
            Smith, K.A., Joziasse, I.C., Chocron, S., van Dinther, M., Guryev, V., Verhoeven, M.C., Rehmann, H., van der Smagt, J.J., Doevendans, P.A., Cuppen, E., Mulder, B.J., Ten Dijke, P., and Bakkers, J. (2009) Dominant-Negative ALK2 Allele Associates With Congenital Heart Defects. Circulation. 119(24):3062-3069.
        
    
                
                    
                        Abstract
                    
                    
                
                
            
        
        
    
        
            
            
 
    
    
        
    
    
    
        
                BACKGROUND: -Serious congenital heart defects occur as a result of improper atrioventricular septum (AVS) development during embryogenesis. Despite extensive knowledge of the genetic control of AVS development, few genetic lesions have been identified that are responsible for AVS-associated congenital heart defects. Methods and Results-We sequenced 32 genes known to be important in AVS development in patients with AVS defects and identified 11 novel coding single-nucleotide polymorphisms that are predicted to impair protein function. We focused on variants identified in the bone morphogenetic protein receptor, ALK2, and subjected 2 identified variants to functional analysis. The coding single-nucleotide polymorphisms R307L and L343P are heterozygous missense substitutions and were each identified in single individuals. The L343P allele had impaired functional activity as measured by in vitro kinase and bone morphogenetic protein-specific transcriptional response assays and dominant-interfering activity in vivo. In vivo analysis of zebrafish embryos injected with ALK2 L343P RNA revealed improper atrioventricular canal formation. Conclusion-These data identify the dominant-negative allele ALK2 L343P in a patient with AVS defects.
            
    
        
        
    
    
    
                
                    
                        Genes / Markers
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Expression
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Phenotype
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mutations / Transgenics
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Human Disease / Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Sequence Targeting Reagents
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Fish
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Orthology
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Engineered Foreign Genes
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mapping
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    